These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 33114328)

  • 1. Cancer-Associated Fibroblasts: Understanding Their Heterogeneity.
    Louault K; Li RR; DeClerck YA
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitors as mediators for immunosuppression by cancer-associated fibroblasts: A comprehensive review.
    Eskandari-Malayeri F; Rezaei M
    Front Immunol; 2022; 13():996145. PubMed ID: 36275750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
    Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
    World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges.
    Hu C; Zhang Y; Wu C; Huang Q
    Cell Death Discov; 2023 Apr; 9(1):124. PubMed ID: 37055382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy.
    Piwocka O; Piotrowski I; Suchorska WM; Kulcenty K
    Front Mol Biosci; 2024; 11():1343523. PubMed ID: 38455762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
    Monteran L; Erez N
    Front Immunol; 2019; 10():1835. PubMed ID: 31428105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.
    Zhou L; Yang K; Andl T; Wickett RR; Zhang Y
    J Cancer; 2015; 6(8):717-26. PubMed ID: 26185533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The recent advances of cancer associated fibroblasts in cancer progression and therapy.
    Wu C; Gu J; Gu H; Zhang X; Zhang X; Ji R
    Front Oncol; 2022; 12():1008843. PubMed ID: 36185262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrotic therapy to normalize the tumor microenvironment.
    Hauge A; Rofstad EK
    J Transl Med; 2020 May; 18(1):207. PubMed ID: 32434573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue.
    Arima Y; Matsueda S; Saya H
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.
    Avagliano A; Granato G; Ruocco MR; Romano V; Belviso I; Carfora A; Montagnani S; Arcucci A
    Biomed Res Int; 2018; 2018():6075403. PubMed ID: 29967776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts.
    Mezawa Y; Orimo A
    FEBS J; 2022 May; 289(9):2429-2447. PubMed ID: 33786982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma.
    Zhang J; Gu C; Song Q; Zhu M; Xu Y; Xiao M; Zheng W
    Cell Biosci; 2020 Oct; 10(1):127. PubMed ID: 33292459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment.
    Houthuijzen JM; Jonkers J
    Cancer Metastasis Rev; 2018 Dec; 37(4):577-597. PubMed ID: 30465162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Associated Fibroblasts in the Hypoxic Tumor Microenvironment.
    Kim I; Choi S; Yoo S; Lee M; Kim IS
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer.
    Sebastian A; Hum NR; Martin KA; Gilmore SF; Peran I; Byers SW; Wheeler EK; Coleman MA; Loots GG
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells.
    Wang Z; Tan Y; Yu W; Zheng S; Zhang S; Sun L; Ding K
    Int J Biol Sci; 2017; 13(3):339-348. PubMed ID: 28367098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.